Lundbeck appoints Tarek Samad R&D chief
Lundbeck R&D chief Tarek Samad has been appointed, effective September 1, 2026, to lead the company's neuroscience research and development.
Lundbeck appoints Tarek Samad R&D chief
Lundbeck R&D chief Tarek Samad has been appointed, effective September 1, 2026, to lead the company's neuroscience research…
Regeneron drug cemdisiran cleared for FDA EMA review
Cemdisiran approval moves forward as Regeneron's drug is cleared for FDA and EMA review, offering hope for adults…
Broken String Biosciences appoints Bruce Eaton as Chairman
Bruce Eaton appointed as Chairman of Broken String Biosciences to drive growth and expand INDUCE-seq platform.